North America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

NEW YORK, Dec. 27, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

North America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

http://www.reportlinker.com/p0739465/North-America-Diabetes-Care-Devices-Market-Outlook-to-2017--Glucose-Monitoring-and-Insulin-Delivery.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

North America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

Summary

GlobalData's new report, "North America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery" provides key market data on the North America Diabetes Care Devices market – Canada and United States. The report provides value (USD million) data for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Scope

- Countries covered include Canada and United States.

- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.

- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.

- 2010 company shares and distribution shares data for each of the market categories and countries.

- Global corporate-level profiles of key companies operating within the North America Diabetes Care Devices market..

- Key players covered include LifeScan, Inc., F. Hoffmann-La Roche Ltd., Medtronic, Inc., Bayer HealthCare AG, Abbott Laboratories, Becton, Dickinson and Company and others.

Reasons to buy

- Develop business strategies by identifying the key market categories and segments poised for strong growth.

- Develop market-entry and market expansion strategies.

- Design competition strategies by identifying who-stands-where in the North America Diabetes Care Devices competitive landscape.

- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.

- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.

1 Table of Contents

1 Table of Contents 2

1.1 List of Tables 7

1.2 List of Figures 9

2 Introduction 10

2.1 What is This Report About? 10

3 Diabetes Care Devices in North America 11

3.1 Diabetes Care Devices Cross Country Comparison, USD Actual, 2003-2017 11

3.2 Diabetes Care Devices, North America, Overall Revenue ($m), USD Actual, 2003-2017 12

3.3 Diabetes Care Devices, North America, Category Volume (Units), 2003-2017 17

3.4 Diabetes Care Devices, North America, Company share (2009-2010) 21

4 Diabetes Care Devices In United States 23

4.1 Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, 2003-2017 23

4.2 Diabetes Care Devices, United States, Category Volume (Units), 2003-2017 28

4.3 Diabetes Care Devices, United States, Distribution Share (2009-2010) 32

4.3.1 Glucose Monitoring, United States, Distribution Share (2009-2010) 32

4.3.2 Insulin Delivery, United States, Distribution Share (2009-2010) 32

4.4 Diabetes Care Devices, United States, Company share (2009-2010) 33

4.4.1 Diabetes Care Devices, United States, Company share (2009-2010) 33

4.4.2 Glucose Monitoring, United States, Company share (2009-2010) 35

4.4.3 Insulin Delivery, United States, Company share (2009-2010) 37

5 Diabetes Care Devices In Canada 39

5.1 Diabetes Care Devices, Canada, Overall Revenue ($m), USD Actual, 2003-2017 39

5.2 Diabetes Care Devices, Canada, Category Volume (Units), 2003-2017 44

5.3 Diabetes Care Devices, Canada, Distribution Share (2009-2010) 47

5.3.1 Glucose Monitoring, Canada, Distribution Share (2009-2010) 47

5.3.2 Insulin Delivery, Canada, Distribution Share (2009-2010) 47

5.4 Diabetes Care Devices, Canada, Company share (2009-2010) 48

5.4.1 Diabetes Care Devices, Canada, Company share (2009-2010) 48

5.4.2 Glucose Monitoring, Canada, Company share (2009-2010) 50

5.4.3 Insulin Delivery, Canada, Company share (2009-2010) 52

6 Overview of Key Companies in North America Diabetes Care Devices Market 54

6.1 LifeScan, Inc. 54

6.1.1 Company Overview 54

6.1.2 Share in the North America Diabetes Care Devices Market 54

6.2 F. Hoffmann-La Roche Ltd. 55

6.2.1 Company Overview 55

6.2.2 Share in the North America Diabetes Care Devices Market 55

6.3 Medtronic, Inc. 56

6.3.1 Company Overview 56

6.3.2 Share in the North America Diabetes Care Devices Market 56

6.4 Bayer HealthCare AG 57

6.4.1 Company Overview 57

6.4.2 Share in the North America Diabetes Care Devices Market 57

6.5 Abbott Laboratories 58

6.5.1 Company Overview 58

6.5.2 Share in the North America Diabetes Care Devices Market 58

6.6 Becton, Dickinson and Company 59

6.6.1 Company Overview 59

6.6.2 Share in the North America Diabetes Care Devices Market 59

6.7 Eli Lilly and Company 60

6.7.1 Company Overview 60

6.8 Animas Corporation 60

6.8.1 Company Overview 60

6.9 Novo Nordisk A/S 60

6.9.1 Company Overview 60

6.10 Sanofi 61

6.10.1 Company Overview 61

6.11 Insulet Corporation 61

6.11.1 Company Overview 61

6.12 NIPRO CORPORATION 61

6.12.1 Company Overview 61

6.13 ARKRAY, Inc. 62

6.13.1 Company Overview 62

6.14 Smiths Medical 62

6.14.1 Company Overview 62

7 Diabetes Care Devices Market Pipeline Products 63

8 Financial Deals Landscape 69

8.1 Acquisition 69

8.1.1 Alere Acquires Arriva Medical from Palm Beach Capital for $83 Million 69

8.1.2 Insulet Acquires Neighborhood Diabetes 70

8.1.3 Sanare Acquires Doctor Diabetic Supply 72

8.1.4 DJO Global Completes Acquisition Of Rikco International 73

8.2 Partnerships 74

8.2.1 Roche Diagnostics Enters Into Distribution Agreement With DexCom 74

8.2.2 Roche Diagnostics Enters Into Research And Development Agreement With DexCom 75

8.2.3 CalAsia Pharmaceuticals Enters Into Co-Development Agreement With Evan Kantrowitz 76

8.2.4 Bayer HealthCare Diabetes Care Expands Partnership With Medtronic 77

8.2.5 PositiveID Enters Into Agreement With HMD BioMedical 78

8.2.6 Insulet Enters Into Distribution Agreement With GlaxoSmithKline 79

8.2.7 Perrigo Enters Into Distribution Agreement With AgaMatrix 80

8.2.8 ZyXEL Communications Enters Into Strategic Partnership With Entra Health Systems 81

9 Recent Developments 82

9.1 Strategy and Business Planning 82

9.1.1 Oct 19, 2011: Abbott to Separate Into Two Leading Companies In Diversified Medical Products And Research-Based Pharmaceuticals 82

9.1.2 Oct 13, 2011: Unisense Establishes US Headquarter 83

9.1.3 May 05, 2011: Medtronic Opens New Distribution Center In Mira Loma, California 84

9.1.4 Mar 08, 2011: Medtronic Inaugurates New Regional Headquarters Building In Greater China 84

9.1.5 Feb 03, 2011: LHC Group Announces Home Health Joint Venture With Baptist Hospital In Pensacola, Florida 85

9.1.6 Jan 04, 2011: NeuroMetrix To Shift Business Focus To Diabetes 85

9.2 Legal and Regulatory 86

9.2.1 Nov 22, 2011: Izard Nobel Announces Class Action Lawsuit Against Hospira 86

9.2.2 Jul 11, 2011: Retractable Technologies Announces Decision From United States Court of Appeals for the Federal Circuit 86

9.2.3 Jun 08, 2011: US District Court Rules In Favor Of Lilly In Amylin Litigation 87

9.2.4 May 25, 2011: Lilly Comments On Court Ruling In Amylin Litigation 87

9.2.5 May 24, 2011: Jensen Law Firm Announces $10m Verdict Against Johnson & Johnson Unit For Toxic Motrin Reaction 87

9.2.6 May 03, 2011: U.S. Senate Finance Committee Announces Investigation Against Medtronic 88

9.2.7 Apr 07, 2011: J&J To Pay $70m To Settle Cases Brought By SEC And Criminal Authorities 88

9.3 Government and Public Interest 89

9.3.1 Oct 14, 2011: MannKind To Present At 18th Annual Newsmakers In BioTech Industry Conference 89

9.3.2 Sep 29, 2011: Research At UC Reveals Hormone Action That Could Lead To Treatments For Type 2 Diabetes 89

9.3.3 Sep 14, 2011: Medtronic Pledges Action In Advance of United Nations High Level Meeting On Noncommunicable Diseases 90

9.3.4 Sep 08, 2011: Sanmina-SCI Kenosha, Wisconsin Facility Receives ISO 13485 Certification For Medical Devices 90

9.3.5 Jul 28, 2011: Verisante Obtains ISO Certification Of Quality Management System For Medical Device Manufacturing 90

9.3.6 Jul 14, 2011: Lilly And Argonne National Laboratory Announce $2m Upgrade To Lilly's Beamline Capabilities 91

9.3.7 Jun 29, 2011: Hospira Supports North Carolina's New Legislation Aimed At Reducing Healthcare-Associated Infections 92

9.3.8 Apr 27, 2011: D. Medical Subsidiaries Achieve Canadian Medical Devices Conformity Assessment System Certification 92

9.3.9 Apr 08, 2011: MannKind Provides Regulatory Update 93

9.3.10 Mar 09, 2011: Medtronic Resolves FDA Warning Letters 93

9.3.11 Feb 25, 2011: Breastfeeding Babies Exposed To Diabetes In Utero Protects Against Childhood Obesity: Study 93

9.3.12 Jan 27, 2011: Guided Therapeutics Receives ISO Certification 94

9.3.13 Jan 27, 2011: China's Ministry Of Commerce Grants Clearance For Merger Of BMP Sunstone And sanofi-aventis Subsidiary 95

9.3.14 Dec 22, 2010: Abbott Recalls Certain Lots Of Precision Xtra, Precision Xceed Pro, MediSense Optium, Optium, OptiumEZ And ReliOn Ultima Blood Glucose Test Strips In US And Puerto Rico 95

9.3.15 Dec 20, 2010: BD Diagnostics Facility In Mebane, North Carolina Achieves LEED Silver Certification For Green Building Design 96

9.3.16 Dec 16, 2010: T-Ray Secures British Columbia's Ministry Of Finance Approval For Venture Capital Program 97

9.4 Product News 98

9.4.1 Oct 28, 2011: ARKRAY's GLUCOCARD Vital And 01 Blood Glucose Meters Are Listed On DoD Uniform Formulary 98

9.4.2 Jun 29, 2010: Medtronic Announces STAR 3 Trial Results Confirming MiniMed Paradigm REAL-Time System Achieves Better Glucose Control Than Daily Insulin Injections In Diabetic Patients 98

9.4.3 Jun 25, 2010: Medtronic Begins Enrollment In ASPIRE Pivotal Study Of MiniMed Paradigm x54 System 99

9.4.4 Mar 17, 2010: Medtronic Announces FDA Approval Of MiniMed Paradigm REAL-Time Revel System 100

10 Appendix 101

10.1 Definitions of Markets Covered in the Report 102

10.1.1 Diabetes Care Devices 102

10.2 Research Methodology 103

10.3 Secondary Research 103

10.4 Primary Research 104

10.5 Models 104

10.6 Forecasts 105

10.7 Expert Panels 105

10.8 GlobalData Consulting 105

10.9 Currency Conversion 106

10.10 Contact Us 106

10.11 Disclaimer 106

List of Tables

Table 1: Diabetes Care Devices, Cross Country Comparison, USD Actual, 2003-2017 11

Table 2: Diabetes Care Devices, North America, Overall Revenue ($m), USD Actual, 2003-2017 12

Table 3: Diabetes Care Devices, North America, Overall Revenue ($m), USD Actual, Historic, 2003-2010 14

Table 4: Diabetes Care Devices, North America, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 16

Table 5: Diabetes Care Devices, North America, Category Volume (Units), 2003-2017 17

Table 6: Diabetes Care Devices, North America, Category Volume (Units), Historic, 2003-2010 19

Table 7: Diabetes Care Devices, North America, Category Volume (Units), Forecast, 2010-2017 20

Table 8: Diabetes Care Devices, North America, Company share by Revenue ($m), USD Actual, 2009-2010 22

Table 9: Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, 2003-2017 23

Table 10: Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, Historic, 2003-2010 25

Table 11: Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 27

Table 12: Diabetes Care Devices, United States, Category Volume (Units), 2003-2017 28

Table 13: Diabetes Care Devices, United States, Category Volume (Units), Historic, 2003-2010 30

Table 14: Diabetes Care Devices, United States, Category Volume (Units), Forecast, 2010-2017 31

Table 15: Glucose Monitoring, United States, Distribution Share by Revenue ($m), USD Actual, 2009-2010 32

Table 16: Insulin Delivery, United States, Distribution Share by Revenue ($m), USD Actual, 2009-2010 32

Table 17: Diabetes Care Devices, United States, Company share by Revenue ($m), USD Actual, 2009-2010 34

Table 18: Glucose Monitoring, United States, Company share by Revenue ($m), USD Actual 2009-2010 36

Table 19: Insulin Delivery, United States, Company share by Revenue ($m), USD Actual 2009-2010 38

Table 20: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Actual, 2003-2017 39

Table 21: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Actual, Historic, 2003-2010 41

Table 22: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 43

Table 23: Diabetes Care Devices, Canada, Category Volume (Units), 2003-2017 44

Table 24: Diabetes Care Devices, Canada, Category Volume (Units), Historic, 2003-2010 45

Table 25: Diabetes Care Devices, Canada, Category Volume (Units), Forecast, 2010-2017 46

Table 26: Glucose Monitoring, Canada, Distribution Share by Revenue ($m), USD Actual, 2009-2010 47

Table 27: Insulin Delivery, Canada, Distribution Share by Revenue ($m), USD Actual, 2009-2010 47

Table 28: Diabetes Care Devices, Canada, Company share by Revenue ($m), USD Actual, 2009-2010 49

Table 29: Glucose Monitoring, Canada, Company share by Revenue ($m), USD Actual 2009-2010 51

Table 30: Insulin Delivery, Canada, Company share by Revenue ($m), USD Actual 2009-2010 53

Table 31: Diabetes Care Devices Market Pipeline Products 63

Table 32: Alere Acquires Arriva Medical From Palm Beach Capital For $83 Million 69

Table 33: Insulet Acquires Neighborhood Diabetes 70

Table 34: Sanare Acquires Doctor Diabetic Supply 72

Table 35: DJO Global Completes Acquisition Of Rikco International 73

Table 36: Roche Diagnostics Enters Into Distribution Agreement With DexCom 74

Table 37: Roche Diagnostics Enters Into Research And Development Agreement With DexCom 75

Table 38: CalAsia Pharmaceuticals Enters Into Co-Development Agreement With Evan Kantrowitz 76

Table 39: Bayer HealthCare Diabetes Care Expands Partnership With Medtronic 77

Table 40: PositiveID Enters Into Agreement With HMD BioMedical 78

Table 41: Insulet Enters Into Distribution Agreement With GlaxoSmithKline 79

Table 42: Perrigo Enters Into Distribution Agreement With AgaMatrix 80

Table 43: ZyXEL Communications Enters Into Strategic Partnership With Entra Health Systems 81

Table 44: USD to Local Currency, North America, Average Exchange Rate 2003-2010 106

List of Figures

Figure 1: Diabetes Care Devices, Cross Country Comparison, USD Actual, 2003-2017 11

Figure 2: Diabetes Care Devices, North America, Overall Revenue ($m), USD Actual, 2003-2017 12

Figure 3: Diabetes Care Devices, North America, Overall Revenue ($m), USD Actual, Historic, 2003-2010 13

Figure 4: Diabetes Care Devices, North America, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 15

Figure 5: Diabetes Care Devices, North America, Category Volume (Units), 2003-2017 17

Figure 6: Diabetes Care Devices, North America, Category Volume (Units), Historic, 2003-2010 18

Figure 7: Diabetes Care Devices, North America, Category Volume (Units), Forecast, 2010-2017 20

Figure 8: Diabetes Care Devices, North America, Company share (%), 2010 21

Figure 9: Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, 2003-2017 23

Figure 10: Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, Historic, 2003-2010 24

Figure 11: Diabetes Care Devices, United States, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 26

Figure 12: Diabetes Care Devices, United States, Category Volume (Units), 2003-2017 28

Figure 13: Diabetes Care Devices, United States, Category Volume (Units), Historic, 2003-2010 29

Figure 14: Diabetes Care Devices, United States, Category Volume (Units), Forecast, 2010-2017 31

Figure 15: Diabetes Care Devices, United States, Company share (%), 2010 33

Figure 16: Glucose Monitoring, United States, Company share (%), 2010 35

Figure 17: Insulin Delivery, United States, Company share (%), 2010 37

Figure 18: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Actual, 2003-2017 39

Figure 19: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Actual, Historic, 2003-2010 40

Figure 20: Diabetes Care Devices, Canada, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 42

Figure 21: Diabetes Care Devices, Canada, Category Volume (Units), 2003-2017 44

Figure 22: Diabetes Care Devices, Canada, Category Volume (Units), Historic, 2003-2010 45

Figure 23: Diabetes Care Devices, Canada, Category Volume (Units), Forecast, 2010-2017 46

Figure 24: Diabetes Care Devices, Canada, Company share (%), 2010 48

Figure 25: Glucose Monitoring, Canada, Company share (%), 2010 50

Figure 26: Insulin Delivery, Canada, Company share (%), 2010 52

Figure 27: LifeScan, Inc., Company Share (%), North America Diabetes Care Devices Market, 2010 54

Figure 28: F. Hoffmann-La Roche Ltd., Company Share (%), North America Diabetes Care Devices Market, 2010 55

Figure 29: Medtronic, Inc., Company Share (%), North America Diabetes Care Devices Market, 2010 56

Figure 30: Bayer HealthCare AG, Company Share (%), North America Diabetes Care Devices Market, 2010 57

Figure 31: Abbott Laboratories, Company Share (%), North America Diabetes Care Devices Market, 2010 58

Figure 32: Becton, Dickinson and Company, Company Share (%), North America Diabetes Care Devices Market, 2010 59

Companies mentioned

LifeScan, Inc.

F. Hoffmann-La Roche Ltd.

Medtronic, Inc.

Bayer HealthCare AG

Abbott Laboratories

Becton, Dickinson and Company

Eli Lilly and Company

Animas Corporation

Novo Nordisk A/S

Sanofi

Insulet Corporation

NIPRO CORPORATION

ARKRAY, Inc.

Smiths Medical

To order this report: Pathology Industry : North America Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery

More  

Market Research Report

Check our  

Industry Analysis and Insights

Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626

SOURCE Reportlinker